SeaStar Medical ICU Investor Presentation September 2024

SeaStar Medical is a commercial-stage medical device company developing the Selective Cytopheretic Device (SCD), an extracorporeal platform designed to treat life-threatening hyperinflammation in critically ill patients. The technology targets cytokine storms and aims to restore organ function across multiple therapeutic applications.